1.3M XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Keith Gottesdiener | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Meredith Goldwasser | SVP, Strategy & Corporate Ops. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 90,500 | 90,500 | - | - | Stock Option (right to buy) | |
| Jeremy Duffield | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 275,000 | 275,000 | - | - | Stock Option (right to buy) | |
| Ann L. Lee | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 275,000 | 275,000 | - | - | Stock Option (right to buy) | |
| Allan Reine | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 275,000 | 275,000 | - | - | Stock Option (right to buy) | |
| Richard H. Brudnick | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 225,000 | 225,000 | - | - | Stock Option (right to buy) | |
| Carman Alenson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 90,500 | 90,500 | - | - | Stock Option (right to buy) | |
| Allan Reine | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 75,000 | 775,000 | - | - | Stock Option (right to buy) | |
| Richard H. Brudnick | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 19,300 | 57,900 | - | - | Stock Option (right to buy) | |
| Keith Gottesdiener | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 100,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Keith Gottesdiener | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Oct 2024 | 226,925 | 50,241 | - | 0 | Common Stock | |
| Keith Gottesdiener | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Oct 2024 | 226,925 | 682,259 | - | 0 | Common Stock | |
| Jeffrey D. Marrazzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Kaye Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| David P. Schenkein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Thomas Cahill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Keith Gottesdiener | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2024 | 250,000 | 2,310,837 | - | 0 | Common Stock | |
| Keith Gottesdiener | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2024 | 250,000 | 277,166 | - | 0 | Common Stock | |
| Ann L. Lee | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 80,416 | 160,832 | - | - | Stock Option (right to buy) | |
| Allan Reine | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Richard H. Brudnick | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 19,300 | 38,600 | - | - | Stock Option (right to buy) | |
| Jeffrey D. Marrazzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Keith Gottesdiener | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Meredith Goldwasser | SVP, Strategy & Corporate Ops. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 90,498 | 90,498 | - | - | Stock Option (right to buy) | |
| Jeremy Duffield | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 180,995 | 180,995 | - | - | Stock Option (right to buy) | |
| Ann L. Lee | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 180,995 | 180,995 | - | - | Stock Option (right to buy) | |
| Brudnick H. Richard | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 135,747 | 135,747 | - | - | Stock Option (right to buy) | |
| Alenson Carman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 90,498 | 90,498 | - | - | Stock Option (right to buy) | |
| Taylor Nelsen Robert | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 15 Feb 2024 | 3,200,000 | 3,200,000 | - | 6.3 | 20,000,000 | Common Stock |
| Allan Reine | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 600,000 | 600,000 | - | - | Stock Option (right to buy) | |
| Thomas Cahill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 39,062 | 39,062 | - | - | Stock Option (right to buy) | |
| Kaye Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 39,062 | 39,062 | - | - | Stock Option (right to buy) | |
| Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 39,062 | 39,062 | - | - | Stock Option (right to buy) | |
| David P. Schenkein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 39,062 | 39,062 | - | - | Stock Option (right to buy) | |
| Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 39,062 | 39,062 | - | - | Stock Option (right to buy) | |
| Jeffrey D. Marrazzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 92,000 | 92,000 | - | - | Stock Option (right to buy) | |
| Meredith Goldwasser | SVP, Strategy & Corporate Ops. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2023 | 4,690 | 4,690 | - | - | Stock Option (right to buy) | |
| Carman Alenson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2023 | 6,254 | 6,254 | - | - | Stock Option (right to buy) | |
| Keith Gottesdiener | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 497,738 | 497,738 | - | - | Stock Option (right to buy) | |
| Meredith Goldwasser | SVP, Strategy & Corporate Ops. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 90,498 | 90,498 | - | - | Stock Option (right to buy) | |
| Jeremy Duffield | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 180,995 | 180,995 | - | - | Stock Option (right to buy) | |
| Ann L. Lee | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 180,995 | 180,995 | - | - | Stock Option (right to buy) | |
| Richard H. Brudnick | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 135,747 | 135,747 | - | - | Stock Option (right to buy) | |
| Carman Alenson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 90,498 | 90,498 | - | - | Stock Option (right to buy) | |
| Robert Taylor Nelsen | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 24 Oct 2022 | 400,000 | 6,128,297 | - | 17 | 6,800,000 | Common Stock |
| Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 1,141,474 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 1,141,474 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 16,666,664 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 16,666,667 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 16,080 | 16,080 | - | - | Common Stock | ||
| Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 49,999 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 5,728,297 | 5,728,297 | - | - | Common Stock | ||
| Robert Taylor Nelsen | Director, Ten Percent Owner | 24 Oct 2022 | 5,728,297 | 5,728,297 | - | - | Common Stock | ||
| Thomas Cahill | Director | 24 Oct 2022 | 4,905,679 | 4,905,679 | - | - | Common Stock | ||
| Thomas Cahill | Director | 24 Oct 2022 | 5,250,781 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Thomas Cahill | Director | 24 Oct 2022 | 9,999,999 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Thomas Cahill | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 24 Oct 2022 | 400,000 | 5,305,679 | - | 17 | 6,800,000 | Common Stock |
| Robert Taylor Nelsen | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 24 Oct 2022 | 400,000 | 6,128,297 | - | 17 | 6,800,000 | Common Stock |
| Kaye Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2022 | 9,006 | 9,006 | - | - | Stock Option (right to buy) | |
| Wendy K. Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2022 | 9,006 | 9,006 | - | - | Stock Option (right to buy) |